Relx (RELX) Return on Sales (2021 - 2022)
On a quarterly basis, Return on Sales rose 247030.0% to 2470.3% in Q4 2022 year-over-year; TTM through Dec 2022 was 4808.6%, a 480860.0% increase, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
Relx (RELX) has 2 years of Return on Sales data on record, last reported at 2470.3% in Q4 2022.
- Return on Sales reached 2470.3% in Q4 2022 per RELX's latest filing, up from 0.0% in the prior quarter.
- Over the last five years, Return on Sales for RELX hit a ceiling of 2470.3% in Q4 2022 and a floor of 0.0% in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Relx | 81.40 Bn | 81.16 Bn | - | - |
| 2 | Rentokil Initial | 79.56 Bn | 78.10 Bn | - | - |
| 3 | Cintas | 69.26 Bn | 69.08 Bn | 1.45 Bn | 0.00% |
| 4 | Copart | 33.09 Bn | 28.01 Bn | 971.24 Mn | 0.00% |
| 5 | UL Solutions | 20.56 Bn | 20.32 Bn | 381.00 Mn | 0.00% |
| 6 | Global Payments | 19.88 Bn | 14.69 Bn | 1.70 Bn | -0.01% |
| 7 | Rb Global | 19.08 Bn | 18.89 Bn | 869.50 Mn | 0.00% |
| 8 | Aramark | 13.57 Bn | 13.16 Bn | 426.35 Mn | 0.00% |
| 9 | Amentum Holdings | 5.65 Bn | 5.74 Bn | 345.00 Mn | 0.00% |
| 10 | Dolby Laboratories | 5.15 Bn | 4.56 Bn | 350.90 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2,470.30% |
| Dec 31, 2021 | 0.00% |